Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DAVE NASDAQ:NVDA NYSE:SMR NASDAQ:TMDX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDAVEDave$389.56-2.8%$295.78$152.21▼$409.00$5.10B3.82566,916 shs418,984 shsNVDANVIDIA$203.69-3.4%$209.57$162.02▼$236.54$5.11T2.21133.35 million shs120.81 million shsSMRNuScale Power$8.37-7.5%$11.02$8.27▼$57.42$3.30B2.2428.25 million shs38.95 million shsTMDXTransMedics Group$75.74+6.3%$71.02$60.10▼$156.00$2.46B1.89986,197 shs1.35 million shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDAVEDave0.00%+3.46%+39.74%+105.38%+97.74%NVDANVIDIA0.00%+8.28%+2.81%+11.44%+27.92%SMRNuScale Power0.00%-6.88%-8.19%-5.33%-75.86%TMDXTransMedics Group0.00%+3.44%-2.30%-37.16%-36.66%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDAVEDave$389.56-2.8%$295.78$152.21▼$409.00$5.10B3.82566,916 shs418,984 shsNVDANVIDIA$203.69-3.4%$209.57$162.02▼$236.54$5.11T2.21133.35 million shs120.81 million shsSMRNuScale Power$8.37-7.5%$11.02$8.27▼$57.42$3.30B2.2428.25 million shs38.95 million shsTMDXTransMedics Group$75.74+6.3%$71.02$60.10▼$156.00$2.46B1.89986,197 shs1.35 million shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDAVEDave0.00%+3.46%+39.74%+105.38%+97.74%NVDANVIDIA0.00%+8.28%+2.81%+11.44%+27.92%SMRNuScale Power0.00%-6.88%-8.19%-5.33%-75.86%TMDXTransMedics Group0.00%+3.44%-2.30%-37.16%-36.66%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDAVEDave 3.00Buy$362.40-6.97% DownsideNVDANVIDIA 3.00Buy$303.8449.17% UpsideSMRNuScale Power 2.19Hold$15.4684.84% UpsideTMDXTransMedics Group 2.38Hold$134.5077.58% UpsideCurrent Analyst Ratings BreakdownLatest TMDX, NVDA, DAVE, and SMR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/13/2026SMRNuScale Power Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$10.007/13/2026DAVEDave Keefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$340.00 ➝ $485.007/9/2026DAVEDave CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform7/9/2026DAVEDave Citizens JmpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetMarket Outperform$365.00 ➝ $450.007/8/2026NVDANVIDIA Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy (B)7/6/2026TMDXTransMedics Group Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell7/1/2026DAVEDave BenchmarkSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$345.00 ➝ $475.007/1/2026DAVEDave BenchmarkSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$345.00 ➝ $475.007/1/2026TMDXTransMedics Group TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$120.006/30/2026DAVEDave Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy (B) ➝ Buy (B-)6/30/2026TMDXTransMedics Group Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$124.00(Data available from 7/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDAVEDave$554.20M8.93$12.51 per share31.14$26.03 per share14.97NVDANVIDIA$215.94B22.83$4.56 per share44.66$6.47 per share31.48SMRNuScale Power$31.48M97.12N/AN/A$3.30 per share2.53TMDXTransMedics Group$605.49M4.32$4.18 per share18.14$13.79 per share5.49Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDAVEDave$195.87M$15.5525.0521.13N/A37.22%77.70%45.59%8/5/2026 (Estimated)NVDANVIDIA$120.07B$6.5331.1917.160.4662.97%96.94%72.16%8/26/2026 (Estimated)SMRNuScale Power-$355.79M-$2.92N/AN/AN/A-2,066.55%-48.88%-38.10%8/5/2026 (Estimated)TMDXTransMedics Group$190.29M$4.4029.0721.52N/A27.04%22.38%8.46%7/30/2026 (Estimated)Latest TMDX, NVDA, DAVE, and SMR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/5/2026Q2 2026DAVEDave$3.42N/AN/AN/A$170.70 millionN/A8/5/2026Q2 2026SMRNuScale Power-$0.13N/AN/AN/A$10.93 millionN/A7/30/2026Q2 2026TMDXTransMedics Group$0.51N/AN/AN/A$184.57 millionN/A5/20/2026Q1 2027NVDANVIDIA$1.76$1.87+$0.11$2.39$78.42 billion$81.62 billion5/7/2026Q1 2026SMRNuScale Power-$0.11-$0.14-$0.03-$0.14$7.00 million$0.57 million5/5/2026Q1 2026DAVEDave$2.86$3.64+$0.78$4.02$153.67 million$158.41 million5/5/2026Q1 2026TMDXTransMedics Group$0.62$0.30-$0.32$0.20$174.44 million$173.93 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthDAVEDaveN/AN/AN/AN/AN/ANVDANVIDIA$1.000.49%+14.87%15.31%1 YearsSMRNuScale PowerN/AN/AN/AN/AN/ATMDXTransMedics GroupN/AN/AN/AN/AN/ALatest TMDX, NVDA, DAVE, and SMR DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/20/2026NVDANVIDIAquarterly$0.250.46%6/4/20266/4/20266/26/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDAVEDave0.953.863.86NVDANVIDIA0.043.442.85SMRNuScale PowerN/A29.3629.36TMDXTransMedics Group1.706.746.19Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDAVEDave18.01%NVDANVIDIA65.27%SMRNuScale Power78.37%TMDXTransMedics Group99.67%Insider OwnershipCompanyInsider OwnershipDAVEDave28.48%NVDANVIDIA3.94%SMRNuScale Power1.28%TMDXTransMedics Group6.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDAVEDave25012.71 million9.09 millionOptionableNVDANVIDIA42,00024.20 billion23.25 billionOptionableSMRNuScale Power440365.48 million360.80 millionOptionableTMDXTransMedics Group21034.56 million32.18 millionOptionableTMDX, NVDA, DAVE, and SMR HeadlinesRecent News About These CompaniesTransMedics Group (NASDAQ:TMDX) Shares Up 6.3% - Time to Buy?July 13 at 11:39 AM | marketbeat.comCandriam S.C.A. Buys 49,580 Shares of TransMedics Group, Inc. $TMDXJuly 12 at 10:47 AM | marketbeat.comIs TransMedics Group, Inc. (TMDX) Stock Still a MedTech Growth Opportunity After Analyst Target Cut?July 8, 2026 | finance.yahoo.comAnalysts Offer Insights on Healthcare Companies: Daiichi Sankyo Company (OtherDSKYF), Vertex Pharmaceuticals (VRTX) and TransMedics Group (TMDX)July 8, 2026 | theglobeandmail.comTransMedics Completes PAD Aviation Investment to Expand in EuropeJuly 7, 2026 | zacks.comTransMedics Group Announces Completion of Strategic Investment in PAD Aviation service GmbHJuly 6, 2026 | prnewswire.comWhere Will TransMedics Group Stock Be in 10 Years?July 3, 2026 | fool.comTMDX stock rallies as analyst sees 77% upside — here’s whyJuly 1, 2026 | msn.comTransMedics: The Margins Must RecoverJuly 1, 2026 | seekingalpha.comReasons to Retain TransMedics Stock in Your Portfolio for NowJune 30, 2026 | zacks.comTransMedics Group (NASDAQ:TMDX) Earns Buy Rating from Canaccord Genuity GroupJune 30, 2026 | marketbeat.comWhat a $722,000 TransMedics Insider Sale Might Mean After a 45% Stock DropJune 25, 2026 | theglobeandmail.comVirtu Financial LLC Buys 22,202 Shares of TransMedics Group, Inc. $TMDXJune 19, 2026 | marketbeat.comTransMedics Group (NASDAQ:TMDX) Price Target Raised to $80.00June 18, 2026 | marketbeat.comInsider Selling: TransMedics Group (NASDAQ:TMDX) Director Sells 9,624 Shares of StockJune 18, 2026 | insidertrades.comJohnson Fistel Investigates TransMedics Group, Inc. (TMDX) After Recent Disclosures Concerning Margin Pressure and NOP InvestmentsJune 12, 2026 | globenewswire.comTransMedics Group Inc.June 11, 2026 | barrons.comTransMedics: Why I'm Still Bullish After The CollapseJune 9, 2026 | seekingalpha.comAnalysts Are Bullish on Top Healthcare Stocks: Charles River Labs (CRL), TransMedics Group (TMDX)June 6, 2026 | theglobeandmail.comWill Analyst Focus on TransMedics’ OCS Platform and Financial Metrics Change TransMedics Group’s (TMDX) Narrative?June 6, 2026 | uk.finance.yahoo.comTransMedics Group, Inc. (TMDX) Presents at 46th Annual William Blair Growth Stock Conference - SlideshowJune 4, 2026 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesThese 5 Companies Just Made a Massive Bet on ThemselvesBy Thomas Hughes | June 15, 2026What to Expect From Q2 Earnings as Tech Strength BroadensBy Thomas Hughes | June 14, 20262 AI Stocks That Could Benefit as AI Moves Beyond the Data CenterBy Thomas Hughes | July 5, 2026SpaceX Was Just the Beginning—2 More Massive IPOs Are on DeckBy Bridget Bennett | June 21, 2026Dave & Buster’s Q1 Miss Raises the Stakes for Its Turnaround PlanBy Thomas Hughes | June 17, 2026TMDX, NVDA, DAVE, and SMR Company DescriptionsDave NASDAQ:DAVE$389.56 -11.19 (-2.79%) Closing price 04:00 PM EasternExtended Trading$383.50 -6.06 (-1.56%) As of 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Dave, Inc. is a digital banking service. Its products include a budgeting tool to help members manage their upcoming bills to avoid overspending, cash advances through its flagship ExtraCash product to help members avoid punitive overdraft fees, a Side Hustle product, where Dave helps connect members with supplemental work opportunities, and Dave Banking, a modern checking account experience with valuable tools for building long-term financial health. The company was founded by Jason Wilk, Paras Chitrakar, and John Wolanin in October 2015 and is headquartered in Los Angeles, CA.NVIDIA NASDAQ:NVDA$203.69 -7.27 (-3.45%) Closing price 03:59 PM EasternExtended Trading$203.23 -0.46 (-0.23%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.NVIDIA Corporation provides graphics and compute and networking solutions in the United States, Taiwan, China, Hong Kong, and internationally. The Graphics segment offers GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; virtual GPU or vGPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse software for building and operating metaverse and 3D internet applications. The Compute & Networking segment comprises Data Center computing platforms and end-to-end networking platforms, including Quantum for InfiniBand and Spectrum for Ethernet; NVIDIA DRIVE automated-driving platform and automotive development agreements; Jetson robotics and other embedded platforms; NVIDIA AI Enterprise and other software; and DGX Cloud software and services. The company's products are used in gaming, professional visualization, data center, and automotive markets. It sells its products to original equipment manufacturers, original device manufacturers, system integrators and distributors, independent software vendors, cloud service providers, consumer internet companies, add-in board manufacturers, distributors, automotive manufacturers and tier-1 automotive suppliers, and other ecosystem participants. NVIDIA Corporation was incorporated in 1993 and is headquartered in Santa Clara, California.NuScale Power NYSE:SMR$8.36 -0.68 (-7.47%) Closing price 03:59 PM EasternExtended Trading$8.24 -0.12 (-1.43%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.NuScale Power Corporation engages in the development and sale of modular light water reactor nuclear power plants to supply energy for electrical generation, district heating, desalination, hydrogen production, and other process heat applications. It offers NuScale Power Module (NPM), a water reactor that can generate 77 megawatts of electricity (MWe); and VOYGR power plant designs for three facility sizes that are capable of housing from one to four and six or twelve NPMs. The company was founded in 2007 and is headquartered in Portland, Oregon. NuScale Power Corporation operates as a subsidiary of Fluor Enterprises, Inc.TransMedics Group NASDAQ:TMDX$75.74 +4.51 (+6.33%) Closing price 04:00 PM EasternExtended Trading$75.72 -0.02 (-0.03%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The SK Hynix IPO and 2027’s AI Memory Squeeze Why Welltower's Growth Story Might Outrun Its Rich Valuation Why Micron Is Doubling Down While the HBM Shortage Persists AMD's 5C Deal Positions It as a Direct NVIDIA Rival China's Helium Ban Could Reshape the AI Supply Chain The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions Analysts See Major Upside for These 5 Stocks One Short- and One Long-Term ETF for Quantum Computing Bulls Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
